DOI:
10.1055/s-00000034
Klinische Pädiatrie
LinksClose Window
References
Gansevoort RT, Arici M, Benzing T. et al.
Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney
disease: a position statement on behalf of the ERA-EDTA Working Groups on
Inherited Kidney Disorders and European Renal Best Practice.
Nephrol Dial Transplant 2016;
31: 337-348
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.